Fijorek Kamil, Tanner Felix C, Stähli Barbara E, Gielerak Grzegorz, Krzesinski Pawel, Uzieblo-Zyczkowska Beata, Smurzynski Pawel, Stanczyk Adam, Stolarz-Skrzypek Katarzyna, Kawecka-Jaszcz Kalina, Jastrzebski Marek, Podolec Mateusz, Kopec Grzegorz, Stanula Barbara, Kocowska Maryla, Tylutki Zofia, Polak Sebastian
Department of Statistics, Cracow University of Economics, Krakow, Poland.
J Cardiovasc Transl Res. 2014 Jul;7(5):507-17. doi: 10.1007/s12265-014-9558-4. Epub 2014 Mar 28.
Correlation of the thickness of the left ventricular posterior wall (LVPWd) with various parameters, including age, gender, weight and height, was investigated in this study using regression models. Multicenter derived database comprised over 4,000 healthy individuals. The developed models were further utilized in the in vitro-in vivo (IVIV) translation of the drug cardiac safety data with use of the mathematical model of human cardiomyocytes operating at the virtual healthy population level. LVPWd was assumed to be equivalent to the length of one-dimensional string of virtual cardiomyocyte cells which was presented, as other physiological factors, to be a parameter influencing the simulated pseudo-ECG (pseudoelectrocardiogram), QTcF and ∆QTcF, both native and modified by exemplar drug (disopyramide) after I Kr current disruption. Simulation results support positive correlation between the LVPWd and QTcF/∆QTc. Developed models allow more detailed description of the virtual population and thus inter-individual variability influence on the drug cardiac safety.
本研究使用回归模型调查了左心室后壁厚度(LVPWd)与包括年龄、性别、体重和身高在内的各种参数之间的相关性。多中心衍生数据库包含4000多名健康个体。所开发的模型进一步用于药物心脏安全性数据的体外-体内(IVIV)转化,使用的是在虚拟健康人群水平运行的人类心肌细胞数学模型。LVPWd被假定等同于虚拟心肌细胞一维串的长度,与其他生理因素一样,它是影响模拟伪心电图(pseudoelectrocardiogram)、QTcF和∆QTcF的一个参数,无论是天然的还是在I Kr电流中断后经典型药物(丙吡胺)修饰后的情况。模拟结果支持LVPWd与QTcF/∆QTc之间存在正相关。所开发的模型能够更详细地描述虚拟人群,从而说明个体间变异性对药物心脏安全性的影响。